title: Inflammation: Targeting the NLRP3 inflammasome after MI.
authors.forename: Gregory B
authors.initials: GB
authors.lastname: Lim
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D004195:Disease Models, Animal; D005663:Furans; D006576:Heterocyclic Compounds, 4 or More Rings / Q000494:pharmacology*; D007192:Indenes; D058847:Inflammasomes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D009206:Myocardium / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013449:Sulfonamides; D013450:Sulfones / Q000494:pharmacology*; D034421:Sus scrofa
chemical_list: D000893:Anti-Inflammatory Agents; D005663:Furans; D006576:Heterocyclic Compounds, 4 or More Rings; D007192:Indenes; D058847:Inflammasomes; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D013449:Sulfonamides; D013450:Sulfones; C000597426:N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide